When we think about Parkinson’s disease, most of us picture trembling hands or a shuffling walk. But what if your nose could ...
Wu Kaimin was worried her dissertation proposal might not be approved. Now, her research could fundamentally alter how ...
Scientists have long struggled to target proteins that lack defined structure and are involved in cancer, neurodegenerative ...
The study also adds to growing research that links oxidative stress—when harmful molecules like nitric oxide build up in the ...
A fluorescent micrograph of a section of brain affected by Parkinson's disease. Neuron nuclei are blue, while the protein ...
Glyoxalase Domain-containing Protein 4 (GLOD4), the First Identified in a New Class of Enzymes Called Nitrases, Generates Nitrated ...
An experimental therapy for Parkinson's disease being developed by ... and also after another alpha-synuclein drug tested in the disease – Biogen's cinpanemab – was abandoned in 2021 after ...
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces the selection of five high priority targets through its Targets to Therapies Initiative — a program aimed at expanding the ...
Researchers in Japan scored a world first by imaging how a substance responsible for Parkinson’s disease and Lewy ... brain cells of a protein called alpha-synuclein. However, alpha-synuclein ...